Punjab manufacturers, reduce costs 20%. Our precision engineering guide compares CNC turning and milling with a ...

Amid an outpouring of industry investments in U.S. drug production, the FDA has launched a new program designed to significantly reduce the complexities involved in setting up domestic manufacturing ...

What just happened? TSMC has begun volume production of chips based on its N2 process technology, marking a major new step in 2nm-class node manufacturing. The company disclosed the milestone on its ...

Semiconductor components have gained universal prominence, playing an essential role in everyday life. They influence global communication, shape interactions, offer amusement, and enable various ...

Companies across sectors have invested in AI at some of their new manufacturing sites. AI can help to increase production, predict machine breakdowns, and forecast demand. This article is part of "How ...

Editor's take: Intel's long-running manufacturing struggles have cost it money and a CEO, highlighting deeper challenges in reclaiming leadership in advanced chip production. As it relies on TSMC for ...

Making 'Made in the USA' work: Inside Bath & Body Works' manufacturing process For more than a decade, Bath & Body Works has been reshoring its production from China, Canada and Mexico. The move to do ...

For more than a decade, Bath & Body Works has been reshoring its production from China, Canada and Mexico. The move to do so has helped the company manufacture, package and deliver products to its ...

Intel's foundry unit aims to rival TSMC CEO Tan committed to improving Intel's foundry Intel on track for high-volume production of 18A process in 2025 SAN JOSE, California, April 29 (Reuters) - Intel ...

Synopsys (NASDAQ:SNPS) announced a broad Electronic Design Automation, or EDA, and Intellectual Property collaboration with Intel Foundry (NASDAQ:INTC). The announcement was made at the Intel Foundry ...

Ten years ago, “Made in America” was a niche claim, made mostly by craft-conscious entrepreneurs. But today, Morgan Stanley is hailing it as a $10 trillion opportunity. At a time when even diseases ...